Form 8-K - Current report:
SEC Accession No. 0001104659-18-005471
Filing Date
2018-01-31
Accepted
2018-01-31 16:13:50
Documents
9
Period of Report
2018-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-4004_28k.htm 8-K 31948
2 EX-1.1 a18-4004_2ex1d1.htm EX-1.1 253747
3 EX-5.1 a18-4004_2ex5d1.htm EX-5.1 13433
4 EX-99.1 a18-4004_2ex99d1.htm EX-99.1 11931
5 EX-99.2 a18-4004_2ex99d2.htm EX-99.2 11869
6 GRAPHIC g40042kgi001.jpg GRAPHIC 1760
7 GRAPHIC g40042kgi002.jpg GRAPHIC 14788
8 GRAPHIC g40042moi001.gif GRAPHIC 4422
9 GRAPHIC g40042mmi001.jpg GRAPHIC 4904
  Complete submission text file 0001104659-18-005471.txt   360404
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 18562888
SIC: 2834 Pharmaceutical Preparations